Search Results - "Cosi, C"

Refine Results
  1. 1

    Biomarkers and clinical predictors of long-term course in obsessivecompulsive disorder: A prospective cohort study by López-Rodriguez, S, P Alonso Ortega, Cosi, C Segalàs, E Real Barrero, Triquell, S Bertolín, C Soriano Mas, Á Carracedo Alvarez, Menchón Magriña, J M

    Published in European psychiatry (01-03-2023)
    “…IntroductionThe purpose of the research project is to analyze the long-term evolution of obsessive-compulsive disorder (OCD) from of a study of a cohort of…”
    Get full text
    Journal Article
  2. 2

    Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist by Newman‐Tancredi, A, Martel, J‐C, Assié, M‐B, Buritova, J, Lauressergues, E, Cosi, C, Heusler, P, Bruins Slot, L, Colpaert, FC, Vacher, B, Cussac, D

    Published in British journal of pharmacology (01-01-2009)
    “…Background and purpose:  Activation of post‐synaptic 5‐HT1A receptors may provide enhanced therapy against depression. We describe the signal transduction…”
    Get full text
    Journal Article
  3. 3

    Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist by Newman‐Tancredi, A, Martel, J‐C, Assié, M‐B, Buritova, J, Lauressergues, E, Cosi, C, Heusler, P, Bruins Slot, L, Colpaert, FC, Vacher, B, Cussac, D

    Published in British journal of pharmacology (01-01-2009)
    “…Background and purpose:  Activation of post‐synaptic 5‐HT 1A receptors may provide enhanced therapy against depression. We describe the signal transduction…”
    Get full text
    Journal Article
  4. 4

    F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile by Newman‐Tancredi, A, Assié, M‐B, Martel, J‐C, Cosi, C, Slot, L Bruins, Palmier, C, Rauly‐Lestienne, I, Colpaert, F, Vacher, B, Cussac, D

    Published in British journal of pharmacology (29-01-2009)
    “…Background and purpose: Combining 5‐HT 1A receptor activation with dopamine D 2 /D 3 receptor blockade should improve negative symptoms and cognitive deficits…”
    Get full text
    Journal Article
  5. 5

    Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia by Colpaert, F C, Tarayre, J P, Koek, W, Pauwels, P J, Bardin, L, Xu, X-J, Wiesenfeld-Hallin, Z, Cosi, C, Carilla-Durand, E, Assié, M B, Vacher, B

    Published in Neuropharmacology (01-11-2002)
    “…We report the discovery of F 13640 and evidence suggesting this agent to produce powerful, broad-spectrum analgesia by novel molecular and neuroadaptative…”
    Get full text
    Journal Article
  6. 6

    Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells by Cosi, C, Suzuki, H, Milani, D, Facci, L, Menegazzi, M, Vantini, G, Kanai, Y, Skaper, S D

    Published in Journal of neuroscience research (01-09-1994)
    “…Glutamate neurotoxicity is correlated with an increase of cytosolic free Ca2+. In some cell systems, activation of Ca2+ dependent endonucleases or formation of…”
    Get more information
    Journal Article
  7. 7
  8. 8

    c-fos mRNA is spontaneously induced in the rat brain during the activity period of the circadian cycle by Grassi-Zucconi, G, Menegazzi, M, De Prati, A C, Bassetti, A, Montagnese, P, Mandile, P, Cosi, C, Bentivoglio, M

    Published in The European journal of neuroscience (01-08-1993)
    “…The basal expression of the proto-oncogene c-fos was studied by Northern blot analysis in different regions of the rat brain during 24 h. A striking…”
    Get more information
    Journal Article
  9. 9

    Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo by Cosi, C, Cavalieri, E, Carcereri de Prati, A, Marien, M, Suzuki, H

    Published in Amino acids (01-01-2000)
    “…Poly(ADP-ribose) polymerase (PARP) is activated in glutamate-induced toxicity of neurons in culture (Cosi et al., 1994). Since injection of the excitatory…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice by Cosi, C

    Published in Brain research (12-08-1996)
    “…Treatment of C57Bl/6 mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduced striatal dopamine and cortical noradrenaline levels by 77-83% and…”
    Get full text
    Journal Article
  12. 12

    F17464 a new antipsychotic with preferential D3 antagonist, 5-HT1A partial agonist properties. Neurochemical studies by Cosi, C., N’Guyen, V., Consul-Denjean, N., Auclair, A., Heusler, P., Martel, J.C., Leriche, L., Sokoloff, P., Gatti-McArthur, S.

    Published in European psychiatry (01-04-2017)
    “…F17464 is a new dopamine receptor antagonist that recently demonstrated antipsychotic activity in a proof of concept study in schizophrenic patients under…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice by Cosi, Cristina, Colpaert, Francis, Koek, Wouter, Degryse, Anne, Marien, Marc

    Published in Brain research (1996)
    “…Treatment of C57B1/6 mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduced striatal dopamine and cortical noradrenaline levels by 77–83% and…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo : Role of 5-HT1A receptor activation by COSI, Cristina, WAGET, Aurelie, ROLLET, Karin, TESORI, Valentina, NEWMAN-TANCREDI, Adrian

    Published in Brain research (10-05-2005)
    “…Excessive activation of non-NMDA receptors, AMPA and kainate, contributes to neuronal degeneration in acute and progressive pathologies, possibly including…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells by Cosi, C, Koek, W

    Published in European journal of pharmacology (14-12-2001)
    “…Agonist and antagonist properties of antipsychotics at human (h) recombinant 5-hydroxytryptamine (h5-HT(1A)) receptor have been examined previously in…”
    Get full text
    Journal Article